China
Africa
Explore chapters and articles related to this topic
Proteomic Profiling and Predictive Biomarkers in Neuro-Traumatology and Neuro-Oncology
Published in Shaker A. Mousa, Raj Bawa, Gerald F. Audette, The Road from Nanomedicine to Precision Medicine, 2020
Mario Ganau, Nikolaos Syrmos, Marco Paris, Lara Prisco
A wide range of laboratory and consumer biotechnological applications, from genetic and proteomic analysis kits to cell culture and manipulation platforms allowing in vitro analyses of established inflammatory, viral, or oncological biomarkers, enable scientists to predict the behavior of cells under various exogenous stimuli [10]. Furthermore, point-of-care diagnostic testing, which enables testing directly at the patient’s bedside, permits physicians to diagnose pathological conditions more rapidly than conventional lab-based testing. By using these devices to reduce the time to diagnosis, the physician is able to make better patient management decisions, leading to improved patient outcomes and reduce the overall cost of care.
Proteomic Profiling and Predictive Biomarkers in Neuro-Traumatology and Neuro-Oncology
Published in Shaker A. Mousa, Raj Bawa, Gerald F. Audette, The Road from Nanomedicine to Precision Medicine, 2019
Mario Ganau, Nikolaos Syrmos, Marco Paris, Lara Prisco
A wide range of laboratory and consumer biotechnological applications, from genetic and proteomic analysis kits to cell culture and manipulation platforms allowing in vitro analyses of established inflammatory, viral, or oncological biomarkers, enable scientists to predict the behavior of cells under various exogenous stimuli [10]. Furthermore, point-of-care diagnostic testing, which enables testing directly at the patient’s bedside, permits physicians to diagnose pathological conditions more rapidly than conventional lab-based testing. By using these devices to reduce the time to diagnosis, the physician is able to make better patient management decisions, leading to improved patient outcomes and reduce the overall cost of care.
Nanosensor Arrays
Published in Suresh Kaushik, Vijay Soni, Efstathia Skotti, Nanosensors for Futuristic Smart and Intelligent Healthcare Systems, 2022
Naumih M. Noah, Peter M. Ndangili
In medical diagnosis, one problem that is faced is that symptoms of some conditions can only arise after a certain amount of time and by the time the symptoms come to the surface, the underlying condition will have advanced to a stage at which its treatment is much more complicated than it would have been had the problem been discovered earlier (McIntosh 2016). Therefore, diseases’ early diagnosis and monitoring of physical conditions are very important for better-quality health management which is crucial in providing better health care to reduce mortality rates and medical care costs (Bhardwaj and Kaushik 2017, Kim et al. 2017, Kaushik and Mujawar 2018, Kaushik et al. 2018, Noah and Ndangili 2019). This can be accomplished by making opportune decisions based on fast diagnostics, smart data analysis, and informatics analysis (Kaushik and Mujawar 2018). Early detection is very crucial for many diseases to provide better treatment since it can increase the probability of curing diseases and significantly improve the mortality rate (Bellah et al. 2012). This demands smart therapeutics, analytical tools, and diagnostics systems to enhance health wellness (Kaushik et al. 2014, Kaushik and Mujawar 2018). Management of a disease progression and monitoring evaluation effectively is important for understanding and controlling the disease and depends on the optimization of therapeutics (Kaushik and Mujawar 2018). Therefore, the development of smart diagnostic systems for personalized health care such as point-of-care devices is imperative. Point-of-care testing ensures fast detection of analytes near to the patient, thereby facilitating a better disease diagnosis, monitoring, and management. It also enables quick medical decisions since the diseases can be diagnosed at an early stage leading to improved health outcomes for the patients and enable them to start early treatment (Vashist 2017).
Development of a wireless passive capacitively coupled contactless conductivity detection (WPC4D) for fluidic flow detection utilizing 3D printing and PCB technologies
Published in Instrumentation Science & Technology, 2023
Bao-Anh Hoang, Van-Anh Bui, Kien Do Trung, Hang Bui Thu, Trinh Chu Duc, Tung Thanh Bui, Loc Do Quang
A diagnostic test at or near the patient’s place of care, known as point-of-care testing (POCT), is one of the critical applications driving the development of microfluidic systems.[23,24] The combination of wireless technology and microfluidic sensors has played a significant role in advancing communication technology and the growing demand for portable healthcare due to convenience and suitability with many various applications. Loc et al. reported a system that provides a passive and wireless readout through which it is possible to analyze the conductivity of a fluidic and detect foreign objects in the fluidic channel.[25]